Table 2 Initial lymphocyte subpopulations levels in patients with RA and controls
Lymphocyte populations | Patient group (n = 31) | Control group (n = 17) | p |
|---|---|---|---|
Lymphocytes | |||
(%) | 23.8 (17.0–30.0) | 18.6 (13.6–28.5) | 0.413 |
(/mm3) | 1600 (1300–2000) | 1700 (1050–1950) | 0.974 |
B lymphocytes | |||
(%) | 11.1 (8.2–17.6) | 10.0 (7.3–14.4) | 0.651 |
(/mm3) | 156 (95–278) | 151 (122–195) | 0.957 |
TCD4+ | |||
(%) | 53.5 (47.0–60.9) | 51.7 (44.8–58.1) | 0.779 |
(/mm3) | 723 (569–1081) | 739 (549–955) | 0.821 |
T2/Breg | |||
(%) | 8.5 (5.9–10.5) | 13.8 (10.9–15.6) | <0.001** |
(/mm3) | 13 (9–22) | 17 (14–31) | 0.014* |
CD24hiCD27+ Breg | |||
(%) | 16.3 (13.1–28.6) | 18.8 (11.9–24.5) | 0.612 |
(/mm3) | 33 (20–45) | 23 (19–34) | 0.185 |
Treg | |||
(%) | 6.4 (4.9–8.1) | 7.1 (6.3–8.3) | 0.223 |
(/mm3) | 49 (35–65) | 56 (44–68) | 0.371 |
Th17 | |||
(%) | 19.6 (13.2–22.7) | 23.4 (18.6–28.4) | 0.036* |
(/mm) | 77 (45–97) | 76 (51–135) | 0.539 |